ArticleOncology letters2019

Increased serum levels of miR-214 in patients with PCa with bone metastasis may serve as a potential biomarker by targeting PTEN.

Yi Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.